Skip to main content
. 2012 Sep 10;14(11):1379–1392. doi: 10.1093/neuonc/nos158

Fig. 1.

Fig. 1.

Anti-VEGF but not VEGF receptor inhibitor therapy prolongs survival in an orthotopic glioma xenograft model. (A) Kaplan–Meier graph showing improved survival in nude mice with U87 tumors treated with bevacizumab (Bev) or sunitinib compared with untreated controls. (B) Kaplan–Meier graph showing improved survival in nude mice with U87 tumors treated with bevacizumab (Bev) + sunititnib compared with bevacizumab alone.